![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
|
![]() | The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
Kimwestclark ( talk) 19:36, 13 February 2020 (UTC)
![]() | This edit request by an editor with a conflict of interest was declined. Per: WP:V. |
This article needs the following statement corrected: “There are several treatments available for bleeding due to factor X deficiency, however a specific FX concentrate is not available (2009).” The reference for this statement is no longer up-to-date regarding current treatment options, and as of September 2018, COAGADEX® (Coagulation Factor X (Human)) is approved by the FDA for the treatment of adults and children with hereditary factor X deficiency. Please see The Genetic and Rare Diseases Information Center (GARD) website: https://rarediseases.info.nih.gov/diseases/6404/factor-x-deficiency
Kimwestclark ( talk) 19:37, 13 February 2020 (UTC)
"a specific FX concentrate is not available". The COI editor proposes that CoagaDex meets the definition of a specific FX concentrate. However, the reference supplied with the request does not state that this agent is an FX concentrate. Please provide references which use and verify the article's terminology. [a]
Regards, Spintendo 21:52, 13 February 2020 (UTC)
Notes
This response is to address the Clarification Request regarding the quote "a specific FX concentrate is not available"
, and the need for a reference which uses the article's terminology and describes Coagadex as an FX concentrate. Please see
https://www.drugs.com/pro/coagadex.html, which addresses the approved indication for Coagadex, and specifically the section located at
https://www.drugs.com/pro/coagadex.html#s-34089-3 which refers to Coagadex as a 'concentrate of human coagulation Factor X'.
Regards,
![]() | This article is rated C-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
|
![]() | The
Wikimedia Foundation's
Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see
WP:PAID. For advice about reviewing paid contributions, see
WP:COIRESPONSE.
|
Kimwestclark ( talk) 19:36, 13 February 2020 (UTC)
![]() | This edit request by an editor with a conflict of interest was declined. Per: WP:V. |
This article needs the following statement corrected: “There are several treatments available for bleeding due to factor X deficiency, however a specific FX concentrate is not available (2009).” The reference for this statement is no longer up-to-date regarding current treatment options, and as of September 2018, COAGADEX® (Coagulation Factor X (Human)) is approved by the FDA for the treatment of adults and children with hereditary factor X deficiency. Please see The Genetic and Rare Diseases Information Center (GARD) website: https://rarediseases.info.nih.gov/diseases/6404/factor-x-deficiency
Kimwestclark ( talk) 19:37, 13 February 2020 (UTC)
"a specific FX concentrate is not available". The COI editor proposes that CoagaDex meets the definition of a specific FX concentrate. However, the reference supplied with the request does not state that this agent is an FX concentrate. Please provide references which use and verify the article's terminology. [a]
Regards, Spintendo 21:52, 13 February 2020 (UTC)
Notes
This response is to address the Clarification Request regarding the quote "a specific FX concentrate is not available"
, and the need for a reference which uses the article's terminology and describes Coagadex as an FX concentrate. Please see
https://www.drugs.com/pro/coagadex.html, which addresses the approved indication for Coagadex, and specifically the section located at
https://www.drugs.com/pro/coagadex.html#s-34089-3 which refers to Coagadex as a 'concentrate of human coagulation Factor X'.
Regards,